Congratulations to Our 2024 Grand Prize and First Place Winners!

NETrolyze, a novel immunotherapy for triple-negative breast cancer (TNBC), was named the $25,000 grand prize winner at a live finalist round held November 15 in New York. The first-in-class therapeutic injectable gel prevents the spread of TNBC, one of the most aggressive cancer types, enabling patients to avoid toxic chemotherapy and expensive treatments – potentially transforming their lives. Click here for the full list of 2024 winners. Also see the Top 100 highest scoring entries.

Special thanks to our esteemed panel of judges.

Help build a better tomorrow

Since Tech Briefs magazine launched the Create the Future Design contest in 2002 to recognize and reward engineering innovation, over 15,000 design ideas have been submitted by engineers, students, and entrepreneurs in more than 100 countries. Join the innovators who dared to dream big by entering your ideas today.

Read About Past Winners’ Success Stories

Special Report spotlights the eight top entries in 2023 as well as past winners whose ideas are now in the market, making a difference in the world.

Click here to read more

A ‘Create the Future’ Winner Featured on ‘Here’s an Idea’

Spinal cord injury affects 17,000 Americans and 700,000 people worldwide each year. A research team at NeuroPair, Inc. won the Grand Prize in the 2023 Create the Future Design Contest for a revolutionary approach to spinal cord repair. In this Here’s an Idea podcast episode, Dr. Johannes Dapprich, NeuroPair’s CEO and founder, discusses their groundbreaking approach that addresses a critical need in the medical field, offering a fast and minimally invasive solution to a long-standing problem.

Listen now

Thank you from our Sponsors

“At COMSOL, we are very excited to recognize innovators and their important work this year. We are grateful for the opportunity to support the Create the Future Design Contest, which is an excellent platform for designers to showcase their ideas and products in front of a worldwide audience. Best of luck to all participants!”

— Bernt Nilsson, Senior Vice President of Marketing, COMSOL, Inc.

“From our beginnings, Mouser has supported engineers, innovators and students. We are proud of our longstanding support for the Create the Future Design Contest and the many innovations it has inspired.”

— Kevin Hess, Senior Vice President of Marketing, Mouser Electronics

Follow Create the Future

GE SpinLab™: First Automated Multichannel Hyperpolarizer

Votes: 47
Views: 15203
Medical

Almost all the major diseases are somehow linked to metabolic alterations. The introduction of Hyperpolarized Metabolic Imaging has opened completely new possibilities to study non-invasively the biochemical changes in disease processes by improving the sensitivity of Magnetic Resonance by more than 20,000-fold (PNAS 2003). GE SpinLab™ harnesses hyperpolarized Carbon 13C (C13) to view metabolic processes in real time. This approach will help researchers to study the real-time metabolism of disease, moving beyond morphology and functionality to reveal visual information about the flow, perfusion, metabolism, and organ and cell viability in living creatures.

The user simply loads the agent into our SpinLab, allows the automated process of hyperpolarization to take place without consideration of the intricate physics, and finally obtains the hyperpolarized agent ready for use. The improvement in sensitivity can be exploited in multiple ways and application including reduced detection limits, accelerated measurement speed and enhanced spatial resolution to investigate low levels of metabolites in cellular and disease models as well as biochemical assays.

To achieve this improvement in sensitivity SpinLab generates an ultra-low temperature (-272 °C or 1 Kelvin) environment in a high magnetic field (5 Tesla) with microwave irradiation (140 GHz) in a fully automated system with an ergonomic user interface. Traditionally, such low temperature is achieved by the evaporation and consumption of large quantities of liquid cryogens, which is costly and inconvenient to the user. Our product reaches this extremely low temperature without any consumption of cryogens. Metabolically relevant agents can are processed with the SpinLab in a custom designed disposable fluid path. The device mechanically and fluidically moves the agent through the processing steps. The fluid path is a highly engineered plastic component that contains the sample of interest and solvents. It tolerates extreme temperature (-272 °C to 150 °C), pressure (to 15 bar) and is chemically resistant. The fluid path ensures a robust process and integrity of the sample and provides the customer with a convenient and automated work flow for sample characterization or biological studies.

Pre-clinical researchers have produced over 500+ publications studying potential applications for this very powerful technology. In 2012, researchers from the University of California at San Francisco, using an early prototype, presented “A first-in-human phase I imaging study using hyperpolarized 1c-13 pyruvate in patients with localized prostate cancer” at the American Society for Clinical Oncology. The innovations in SpinLab have automated the concept and complex physics of hyperpolarization to enable researchers to explore in vitro and in vivo biochemistry in real-time.

  • Awards

  • 2012 Top 100 Entries

Voting

Voting is closed!

  • ABOUT THE ENTRANT

  • Name:
    Jonathan Murray
  • Type of entry:
    team
    Team members:
    Jonathan Murray
    Andrew Leach
    Jan Henrik Ardenkjaer-Larsen
    Tim Skloss
  • Software used for this entry:
    solidworks
  • Patent status:
    patented